Will the new ESC NSTE-ACS Guidelines released in London make you reconsider that practice?
EU:2015 ESC guidelines for NSTE-ACS
A P2Y12inhibitor is recommended, in addition to aspirin, for 12 months
"As the optimal timing of ticagrelor or clopidogrel administration in NSTE-ACS patients scheduled for an invasive strategy has not been adequately investigated, no recommendation for or against pretreatment with these agents can be formulated. Based on the ACCOAST results, pretreatment with prasugrel is not recommended."